https://www.indianpharmapost.com/sun-pharma-signs-cassiopea-for-license-and-supply-agreements-97782021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/kilitch-starts-injectables-production-at-ethiopia-97812021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/sun-pharma-advanced-research-company-q1fy22-loss-at-rs-6137-cr-97822021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/glaxosmithkline-delivers-19-revenue-growth-for-q1-fy22-97832021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-pharmaceuticals-q1fy22-net-slides-to-rs-16452-cr-97852021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/lasa-production-to-commence-in-couple-of-weeks-97902021-07-27T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-partners-adagio-to-manufacture-antibody-for-covid-19-97912021-07-27T00:00:00+05:30always0.9